PATENT CLAIM ANALYSIS

Application Number: 15878351
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "130100"]

Abstract:
A method for providing information relevant to the diagnosis of a neurodegenerative disorder. The method includes (i) obtaining a biological sample containing vesicles from a subject, (ii) measuring the level of amyloid beta in the biological sample using an antibody specific for the N-terminus of amyloid beta, and (iii) comparing the measured level of amyloid beta in the biological sample with the level of amyloid beta in a previously prepared control sample.

Claim (Index 11):
The method according to  claim 1 , wherein the neurodegenerative disorder is selected from the group consisting of Alzheimer's disease (AD), vascular disease dementia, frontotemporal dementia (FTD), corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), Lewy body dementia, tangle-predominant senile dementia, Pick's disease (PiD), argyrophilic grain disease, amyotrophic lateral sclerosis (ALS), other motor neuron diseases, Guam parkinsonism-dementia complex, FTDP-17, Lytico-Bodig disease, multiple sclerosis, traumatic brain injury (TBI), and Parkinson's disease.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 86.0
- Lexical Diversity: 1.78261
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14522585', '15179761', '13000303', '15600959', '11574844']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7569412842185959
- 35 USC 102 Novelty (BERT): 0.5228179519272913
- Combined Prediction Score: 0.7335289509894655
- Mean Citation Score: 295.834244
- Max Citation Score: 331.00858
- Similarity Product: 292.89093792262315

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test